# Health Economics Evaluation of the Management of Severe Postpartum Hemorrhage: Comparison of Recombinant Activated Factor VII Strategy to the Reference Strategy

> **NCT02900690** · — · TERMINATED · sponsor: **Centre Hospitalier Universitaire de Nīmes** · enrollment: 84 (actual)

## Conditions studied

- Health Care Cost
- Post Partum Haemorrhage

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02900690
- **Lead sponsor:** Centre Hospitalier Universitaire de Nīmes
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2010-04-22
- **Primary completion:** 2010-11-05
- **Final completion:** 2010-11-05
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2018-03-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02900690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02900690, "Health Economics Evaluation of the Management of Severe Postpartum Hemorrhage: Comparison of Recombinant Activated Factor VII Strategy to the Reference Strategy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02900690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*